State of the Art in Dendritic Cell Vaccination
暂无分享,去创建一个
[1] C. Figdor,et al. Phenotypical and Functional Characterization of Clinical Grade Dendritic Cells , 2002, Journal of immunotherapy.
[2] W. Oyen,et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. , 2003, Cancer research.
[3] T. Di Pucchio,et al. Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. , 2001, Blood.
[4] Antonio Lanzavecchia,et al. Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.
[5] Frank O. Nestle,et al. Dendritic cells: On the move from bench to bedside , 2001, Nature Medicine.
[6] K. Matsushima,et al. Mammalian and Viral IL-10 Enhance C-C Chemokine Receptor 5 but Down-Regulate C-C Chemokine Receptor 7 Expression by Myeloid Dendritic Cells: Impact on Chemotactic Responses and In Vivo Homing Ability1 , 2001, The Journal of Immunology.
[7] G. Schuler,et al. Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells. , 2000, The Journal of investigative dermatology.
[8] A. Enk,et al. Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma , 1999, The Journal of experimental medicine.
[9] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[10] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[11] D. Hart,et al. Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.
[12] P. Bruggen,et al. T cell defined tumor antigens , 1997 .
[13] Edgar G. Engleman,et al. Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells , 1996, Nature Medicine.
[14] C. Figdor,et al. Identification of a novel peptide derived from the melanocyte‐specific gp100 antigen as the dominant epitope recognized by an HLA‐A2.1‐restricted anti‐melanoma CTL line , 1995, International journal of cancer.
[15] R. Steinman,et al. Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.
[16] H. Grey,et al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Coulie,et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1993, The Journal of experimental medicine.